Evidence map›Paper›PMID 39543866›Full record

ArticleKorean journal of radiology2024

Survey of Experts' Opinions on the Diagnosis and Management of Pancreatic Cystic Neoplasms.

Jeong Hee Yoon, In Rae Cho, Won Chang, Bohyun Kim, Siwon Jang, Yeun-Yoon Kim, Jeong Woo Kim, Sang Hyub Lee, Jeong Min Lee

Abstract read
In one paragraph

Article in Korean journal of radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Endoscopic management of pancreatic cystic neoplasms.World journal of gastrointestinal oncology · 2025
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Jeong Hee Yoon *Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea.ORCID 0000-0002-9925-9973
In Rae Cho *Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0001-9874-5526
Won ChangDepartment of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0001-7367-9841
Bohyun KimDepartment of Radiology, Seoul St. Mary's Hospital & College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.ORCID 0000-0003-1157-415X
Siwon JangDepartment of Radiology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea.ORCID 0000-0002-6980-431X
Yeun-Yoon KimDepartment of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.ORCID 0000-0003-2018-5332
Jeong Woo KimDepartment of Radiology, Korea University Guro Hospital & College of Medicine, Seoul, Republic of Korea.ORCID 0000-0003-1580-1006
Sang Hyub LeeDepartment of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea. gidoctor@snu.ac.kr.ORCID 0000-0003-2174-9726
Jeong Min LeeDepartment of Radiology, Seoul National University Hospital, Seoul, Republic of Korea.ORCID 0000-0003-0561-8777

Funding

National Cancer Center HA21C0143000021NRF 2020R1A2C2006031
6 · The paper itself

Abstract

objectiveTo survey experts' opinions in abdominal radiology (radiologists) and pancreas-specialized gastroenterology (pancreatologists) in South Korea regarding diagnosing and managing pancreatic cystic neoplasms (PCNs). MATERIALS AND

methodsBetween August 25, 2023, and October 5, 2023, an online survey was conducted among members of the Korean Society of Abdominal Radiology and the Korean Pancreatobiliary Association via email invitation.

resultsThe responses from 100 radiologists and 41 pancreatologists were analyzed. Of the respondents, 55.3% (78/141) reported seeing more than 50 patients or reading more than 50 exams related to PCN each month. The most common and preferred diagnostic modality for PCN was contrast-enhanced computed tomography (CECT), favored by 87.8% (36/41) of pancreatologists. When discrepancies arose between CECT or magnetic resonance imaging (MRI) and endoscopic ultrasound, 31.2% (44/141) of the respondents opted for multidisciplinary team discussion, whereas 29.1% (41/141) chose short-term follow-up using CECT or MRI. A total of 88.7% (125/141) of the respondents adhered to the 2017 International Association of Pancreatology (IAP) guidelines in their practice. Among the radiologists, 51.0% (51/100) endorsed a cut-off value of 5 mm for enhancing mural nodules, and 22.0% (22/100) supported a 5 mm/2 yr growth rate in the IAP guidelines v.2017. Additionally, 73.0% (73/100) of radiologists favored discontinuing surveillance, whereas 41.5% (17/41) of pancreatologists disagreed with stopping surveillance.

conclusionThe survey underscores the clinical burden PCN poses and identifies CECT as the foremost diagnostic tool. Variability was noted in the terminology, differential diagnosis, approaches for resolving discrepancies between imaging examinations, and opinions on surveillance discontinuation among the respondents as a whole, as well as between radiologists and pancreatologists. Although the 2017 IAP guidelines are primarily followed, there remains a level of dissatisfaction with risk stratification among radiologists. This highlights the need for more standardized diagnostic algorithms and improved consensus among specialists to address these challenges.

Indexed as

Pancreatic NeoplasmsContrast MediaHumansMagnetic Resonance ImagingPancreatic CystPractice Patterns, Physicians'RadiologistsRepublic of KoreaSurveys and QuestionnairesTomography, X-Ray ComputedContrast MediaConsensusCystGuidelineImagingIntraductal papillary mucinous neoplasmPancreasPancreatic cystic neoplasmRecommendationSurveillance

Identifiers

PMID39543866
PMCPMC11604339

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.